Dr. Lapuebla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11104 Parkview Circle Dr
Ste 440
Fort Wayne, IN 46845Phone+1 260-373-9935Fax+1 260-373-9926
Education & Training
- SUNY Downstate Health Sciences UniversityFellowship, Infectious Disease, 2013 - 2015
- Harlem Hospital CenterResidency, Internal Medicine, 2010 - 2013
- University of the Philippines College of MedicineClass of 2008
Certifications & Licensure
- IN State Medical License 2018 - 2025
- MA State Medical License 2015 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 112 citationsActivity of meropenem combined with RPX7009, a novel β-lactamase inhibitor, against Gram-negative clinical isolates in New York CityAmabel Lapuebla, Marie Abdallah, Olawole Olafisoye, Christopher Cortes, Carl Urban
Antimicrobial Agents and Chemotherapy. 2015-08-01 - 141 citationsActivity of Imipenem with Relebactam against Gram-Negative Pathogens from New York CityAmabel Lapuebla, Marie Abdallah, Olawole Olafisoye, Christopher Cortes, Carl Urban
Antimicrobial Agents and Chemotherapy. 2015-08-01 - 10 citationsIn Vitro and In Vivo Activity of a Novel Antisense Peptide Nucleic Acid Compound Against Multidrug-Resistant Acinetobacter baumanniiMichael Rose, Amabel Lapuebla, David Landman, John Quale
Microbial Drug Resistance. 2019-09-09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: